<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NIC-T-INSS-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis - Nicaragua (01-Jul-2016-31-Dec-2018)</narrative>
    </title>
    <description type="1">
      <narrative>Nicaragua, Tuberculosis, Instituto Nicaragüense de Seguridad Social</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce the TB burden at 25% by 2020; Reduce the TB mortality rate in 35% by 2020. Objectives: Contribute to operational , epidemiological and clinical research, implementation of initiatives and new technologies of rapid diagnostics for tuberculosis control; Contribute to the prevention and integrated TB care focusing on people affected by Tuberculosis; Strengthen the political commitment , the capacity of the National Program , communities , social organizations, public and private providers in prevention, care and TB control.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="15" role="2" crs-channel-code="12004">
      <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
    </participating-org>
    <participating-org type="15" role="4" crs-channel-code="12004">
      <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
    </participating-org>
    <other-identifier ref="NIC-T-INSSP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-07-01" />
    <activity-date type="2" iso-date="2016-07-01" />
    <activity-date type="3" iso-date="2018-12-31" />
    <activity-date type="4" iso-date="2018-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Noemie Restrepo</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>noemie.restrepo@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NI" percentage="100">
      <narrative>Nicaragua</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="f4bf2686-7c34-4255-bfcd-1c596e2bf89e">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-01" />
      <value currency="USD" value-date="2016-07-01">3997017.00</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b1a2b4b0-de09-4545-8ce3-d3f7c821a3f6">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-05" />
      <value currency="USD" value-date="2016-07-05">1498982.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a4644232-fde6-4dba-88b9-ccb570244ade">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-22" />
      <value currency="USD" value-date="2016-09-22">606205.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a378e260-3fa3-47e1-816f-c2615dc6f945">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-03" />
      <value currency="USD" value-date="2017-01-03">1891830.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="06329f2f-242c-4f1e-b0d3-eca727d00f9a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-06-30" />
      <value currency="USD" value-date="2017-06-30">2590254.00</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba359c3c-dfdf-4fa1-90d9-063f55112a81">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-04" />
      <value currency="USD" value-date="2017-07-04">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8021bdf-3bb1-456f-875e-7af4c349a639">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-04" />
      <value currency="USD" value-date="2017-07-04">468339.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="faeded80-bbbb-4dd1-8dc7-f8b822fe6da9">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-09-29" />
      <value currency="USD" value-date="2017-09-29">460969.11</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="18909687-63d8-46df-a05e-684928c2eec0">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b701b9ad-06b8-471a-abde-e63e28c6705b">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c30fba8-44ab-42e0-8324-72847fc6dcc6">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-11" />
      <value currency="USD" value-date="2018-01-11">1229622.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="23b62504-cfaf-4110-896b-8523058ea276">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-04-05" />
      <value currency="USD" value-date="2018-04-05">280632.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="75ee1731-cfb2-4b5d-b74c-d9829725690f">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-07" />
      <value currency="USD" value-date="2018-05-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c1f2c7bf-538b-40d0-9605-c206889c77a6">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-06-27" />
      <value currency="USD" value-date="2018-06-27">-100691.89</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="51d9e19f-85dc-4006-b14d-66265a35d6d8">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-30" />
      <value currency="USD" value-date="2018-11-30">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a59ea494-3e5d-43be-8b43-d693a1b04e1a">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-11" />
      <value currency="USD" value-date="2018-12-11">14835.00</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="35bdf23c-ae79-4e30-ae6e-806c5fd85c6d">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-13" />
      <value currency="USD" value-date="2018-12-13">14835.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f0c04a1f-1ef8-4758-8ac3-4b35b95a49b8">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-05-01" />
      <value currency="USD" value-date="2020-05-01">461018.95</value>
      <description>
        <narrative>Funds returned to the Global Fund from NIC-T-INSSP01.</narrative>
      </description>
      <provider-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2b99343d-3907-4139-bfff-a73b17c494b3">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-04" />
      <value currency="USD" value-date="2020-05-04">-461018.95</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NIC-T-INSS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 18.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 16; Denominator: 16; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 7; Denominator: 16; Percentage: 43.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9; Denominator: 16; Percentage: 56.25%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 19.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 41.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 37; Denominator: 41; Percentage: 90.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 44.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 16.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 20.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 20; Denominator: 20; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8; Denominator: 20; Percentage: 40%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 12; Denominator: 20; Percentage: 60%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 0; Denominator: 20; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 0; Denominator: 20; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 18.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 36; Denominator: 37; Percentage: 97.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 13.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 2632.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1093; Denominator: 2632; Percentage: 41.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1539; Denominator: 2632; Percentage: 58.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 447; Denominator: 2632; Percentage: 16.98%.</narrative>
          </comment>
        </baseline>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 1577; Denominator: 2632; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1567.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1126.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3296.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2255; Denominator: 2387; Percentage: 94.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3498.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2109.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1620.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 827.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1282.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1927.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 134.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 48.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NIC-T-INSS-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Nicaragua joined together for a sustainable national response in the reduction of tuberculosis and mortality, with emphasis on vulnerable populations and based on a family and community health model - Nicaragua (01-Jan-2019-30-Jun-2019)</narrative>
    </title>
    <description type="1">
      <narrative>Nicaragua, Tuberculosis, Instituto Nicaragüense de Seguridad Social</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce the TB burden at 25% by 2020 // Reducir la Carga de TB en 25% al 2020; Reduce the TB mortality rate in 35% by 2020 // Reducir la mortalidad de TB en 35% al 2020. Objectives: Contribute to the prevention and integrated TB care focusing on people affected by Tuberculosis // Contribuir en la prevención y la atención integrada de la TB centrada en personas afectadas por Tuberculosis; Strengthen the political commitment , the capacity of the National Program , communities , social organizations, public and private providers in prevention, care and TB control // Fortalecer el compromiso político, la capacidad del Programa Nacional, las comunidades, organizaciones sociales y  proveedores público privados  en la prevención, atención  y control de la TB; Contribute to operational, epidemiological and clinical research, implementation of initiatives and new technologies of rapid diagnostics for tuberculosis control // Contribuir con la investigación operativa, epidemiológica y clínica, implementación de iniciativas y nuevas tecnologías de diagnósticos rápidos para el control de la tuberculosis.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="15" role="2" crs-channel-code="12004">
      <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
    </participating-org>
    <participating-org type="15" role="4" crs-channel-code="12004">
      <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
    </participating-org>
    <other-identifier ref="NIC-T-INSSP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-01-01" />
    <activity-date type="2" iso-date="2019-01-01" />
    <activity-date type="3" iso-date="2019-06-30" />
    <activity-date type="4" iso-date="2019-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Noemie Restrepo</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>noemie.restrepo@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NI" percentage="100">
      <narrative>Nicaragua</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="67.36">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="32.64">
      <narrative>Multicomponent</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="13.66">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="18.98">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="7.23">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="29.56">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="29.23">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="1.34">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">553831.90</value>
    </budget>
    <capital-spend percentage="11.68" />
    <transaction ref="4c033a97-cd98-4aa8-aae3-c5c1f99197b1">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-13" />
      <value currency="USD" value-date="2018-12-13">2385030.79</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="de754716-234d-428c-93cb-35e384876270">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-03" />
      <value currency="USD" value-date="2019-01-03">462224.93</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a86bb7e5-917a-46af-aabe-598d5cd88ad8">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-27" />
      <value currency="USD" value-date="2019-06-27">3104.86</value>
      <description>
        <narrative>Global Fund disbursement to NIC-T-INSSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="473b690f-b1aa-49ac-a4d4-810d167c5dd7">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-08" />
      <value currency="USD" value-date="2019-07-08">-1919701.00</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="586956eb-7a9c-43da-af77-a458a4579fdf">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-08" />
      <value currency="USD" value-date="2019-07-08">0.00</value>
      <description>
        <narrative>Global Fund commitment to NIC-T-INSSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="NIC-T-INSSP02-EXP-20190630">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-06-30" />
      <value currency="USD" value-date="2019-06-30">448699.73</value>
      <description>
        <narrative>Expenditure reported by Instituto Nicaragüense de Seguridad Social for NIC-T-INSSP02, Jan 2019 to Jun 2019.</narrative>
      </description>
      <provider-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NIC-T-INSSP02-EXP-20190930">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-09-30" />
      <value currency="USD" value-date="2019-09-30">78559.70</value>
      <description>
        <narrative>Expenditure reported by Instituto Nicaragüense de Seguridad Social for NIC-T-INSSP02, Jul 2019 to Sep 2019.</narrative>
      </description>
      <provider-org type="15">
        <narrative>Instituto Nicaragüense de Seguridad Social</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NIC-T-INSS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 37; Denominator: 36; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 37; Denominator: 37; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 37; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 13; Denominator: 37; Percentage: 35.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 24; Denominator: 37; Percentage: 64.9%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 21.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 18.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 36.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 36; Denominator: 36; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 36; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 13; Denominator: 36; Percentage: 36.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 23; Denominator: 36; Percentage: 63.9%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 16.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 2255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2083; Denominator: 2255; Percentage: 92.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 172; Denominator: 2255; Percentage: 7.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 1750; Denominator: 2255; Percentage: 77.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 894; Denominator: 2255; Percentage: 39.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1361; Denominator: 2255; Percentage: 60.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2080; Denominator: 2255; Percentage: 92.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 131; Denominator: 2255; Percentage: 5.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 44; Denominator: 2255; Percentage: 2%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1049.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1134.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1042.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 92.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 867.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 451.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 683.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1038.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 62.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="96.7">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 2020.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="86.36">
          <comment>
            <narrative>Numerator: 2020; Denominator: 2339.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90" />
          <actual value="87.2">
            <comment>
              <narrative>Numerator: 926; Denominator: 1062.</narrative>
            </comment>
          </actual>
          <actual value="86.6">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 856; Denominator: 989.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>